Ono Pharmaceutical (OPHLY) News Today → The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad) Free OPHLY Stock Alerts $4.89 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShort Interest in Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Drops By 23.8%americanbankingnews.com - April 15 at 6:18 AMOno signs licence deal with NEX-I for cancer therapymsn.com - March 6 at 4:33 PMFate Therapeutics Inc (FATE) Reports Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - February 26 at 5:36 PMInveniAI Announces Collaboration with Ono Pharmaceutical for Target Discoverymarkets.businessinsider.com - February 19 at 8:22 AMOno Pharmaceutical Co., Ltd. (OPHLY)finance.yahoo.com - February 15 at 3:02 PMNumab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancerglobenewswire.com - February 14 at 3:00 AMOno Pharmaceutical Co. Ltd.barrons.com - February 10 at 6:52 PMOno Pharmaceutical earnings preview: what Wall Street is expectingmarkets.businessinsider.com - January 30 at 8:46 PMCall for Application to Researchers for Joint Research Project between Ono Pharmaceutical and BioMed Xfinance.yahoo.com - January 9 at 8:13 AMThe BioMed X Institute: BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Researchfinanznachrichten.de - December 19 at 9:28 AMNikkei Edges 0.2% Lower Amid JPY Strengthfinance.yahoo.com - November 28 at 7:30 PMChina Shares Open Lower; Infrastructure Stocks Weighfinance.yahoo.com - November 27 at 10:45 PMOno Pharmaceutical Co. Ltd - ADR (OPHLY) Price Target Increased by 10.78% to 7.59msn.com - October 5 at 10:09 AMTwist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseasesfinance.yahoo.com - August 31 at 4:29 AMTwist Bioscience To Develop Novel Antibodies With Ono Pharmamarkets.businessinsider.com - August 31 at 4:29 AMQ2 2023 Fate Therapeutics Inc Earnings Callfinance.yahoo.com - August 9 at 1:18 PMOno Pharmaceutical Co. Ltd - ADR (OPHLY) Price Target Decreased by 29.33% to 6.89msn.com - August 3 at 4:16 PMMacomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy for the Treatment of Cancertechnews.tmcnet.com - March 23 at 7:51 AMMemo Therapeutics AG and Ono Pharmaceutical Enter Antibody Discovery Partnership for Immuno-oncology Targetsbenzinga.com - November 1 at 4:55 AM3 Reasons Why Ono Pharmaceutical Co. (OPHLF) Is a Great Growth Stockfinance.yahoo.com - September 19 at 3:47 PMFate Therapeutics: Yes For Speculators, No For Defensive Investorsseekingalpha.com - August 30 at 5:04 PMOno Pharmaceutical (OTC:OPHLY), Earnings Estimates, EPS, and Revenuebenzinga.com - July 18 at 11:29 PMOno Pharmaceutical (OTC:OPHLY), Analyst Ratings, Price Targets, Predictionsbenzinga.com - July 18 at 6:21 PMCan Ono Pharmaceutical Co ride out the impact of economic shocks?uk.finance.yahoo.com - July 7 at 2:24 AMOno Pharmaceutical Co. Ltd ADR (OPHLY)nasdaq.com - January 23 at 12:52 AMHere's what to expect from ONO PHARMACEUTICAL's earnings reportmarkets.businessinsider.com - November 8 at 7:46 PM Get Ono Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode April 20th? (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 OPHLY Media Mentions By Week OPHLY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPHLY News Sentiment▼0.000.43▲Average Medical News Sentiment OPHLY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPHLY Articles This Week▼00▲OPHLY Articles Average Week Get Ono Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AZNCF News CMOPF News DSNKY News JCRRF News KYKOF News MAYNF News OPHLF News OTSKF News RHHVF News SNYNF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OPHLY) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ono Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
